surmount-1 tirzepatide 15 mg weight loss percent Adults with obesity using maintain 'remarkable' at 88 weeks SURMOUNT‐1 study design. This is

Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination

Not a replacement for approved medical therapies

For patients using these medications to manage obesity including those who had pre-diabetes, metabolic syndrome, or significant cardiovascular risk that restriction can feel deeply unfair, particularly if the medication was working

Maintaining a robust antioxidant defense system is essential for supporting cellular health for both the mother and the baby

10.1007/s12253-015-9946-3 91 LouandreC.EzzoukhryZ.GodinC.BarbareJ

Arm Injection Steps (Caregiver Needed) The arm injection process is the same as the thigh, except a caregiver or partner should administer it